Analyst stock forecast
Monopar Therapeutics Forecast: $129.92 Analyst Target
Direct answer
Monopar Therapeutics's average price target is $129.92.
The target implies +87.6% from the recorded current price, and the consensus rating is none.
The low target implies +71.8%, the high target implies +109.3%, and the range spans 37.5% of the current price.
Forecast evidence checked October 19, 2026.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $69.27
- Average price target
- $129.92
- High price target
- $145.00
- Low price target
- $119.00
- Low target gap
- +71.8%
- Target upside
- +87.6%
- High target gap
- +109.3%
- Target range width
- 37.5%
- Consensus rating
- none
- Analysts
- 12
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is Monopar Therapeutics's average price target?
Monopar Therapeutics's verified average price target is $129.92. The target range is $119.00 to $145.00.
How far are Monopar Therapeutics's low and high targets from the recorded price?
The low target implies +71.8%, while the high target implies +109.3%.
How many analysts are included in Monopar Therapeutics's consensus?
The verified consensus includes 12 analysts.
How is Monopar Therapeutics's target upside or downside calculated?
The average target of $129.92 is divided by the recorded price of $69.27, then one is subtracted to produce +87.6%. This does not guarantee a future return.
When was Monopar Therapeutics's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.